ICC Melanoma 2020

Translate the description into English (United States) using Google Translate?Translate the description back to Italian (Italy)

COME GESTIRE LA TOSSICITÀ E VALUTARE LA RISPOSTA ALL’IMMUNOTERAPIA NEI PAZIENTI CON MELANOMA

La terapia immunologica del melanoma sta attraversando una fase di grande evoluzione, grazie agli importanti risultati ottenuti in molti studi clinici, a partire dal 2010, a seguito dell’introduzione degli anticorpi diretti contro i checkpoint immunologici come CTLA-4 e, in particolare, PD-1. Lo scopo di questo progetto è di approfondire i principali scenari di difficile gestione del paziente affetto da melanoma in terapia con anticorpi ant-PD-1, attraverso esempi di situazioni cliniche interattive.
HOW TO MANAGE TOXICITY AND ASSESS THE ANSWER TO IMMUNOTHERAPY IN MELANOMA PATIENTS

The immunological therapy of melanoma is going through a phase of great evolution, thanks to the important results obtained in many clinical studies, starting from 2010, following the introduction of antibodies against immunological checkpoints such as CTLA-4 and, in particular, PD -1. The purpose of this project is to investigate the main scenarios of difficult management of melanoma patients treated with ant-PD-1 antibodies, through examples of interactive clinical situations.
Read more
Collapse
Loading…

What's New

Aggiornamento riferimenti per corso FAD 2020
Read more
Collapse

Additional Information

Updated
March 30, 2020
Size
Varies with device
Installs
10+
Current Version
2.0
Requires Android
4.1 and up
Content Rating
Everyone
Interactive Elements
Users Interact
Permissions
Offered By
Forum Service s.r.l.
Developer
Via Martin Piaggio 17/6 16122 Genova GE
©2021 GoogleSite Terms of ServicePrivacyDevelopersAbout Google|Location: United StatesLanguage: English (United States)
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.